Stay updated on Pembrolizumab Combo with Chemo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo with Chemo in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo with Chemo in NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe page now includes additional related topics links, listing Lung cancer and MedlinePlus Genetics, enriching the page with quick access to educational resources related to the study.SummaryDifference0.1%

- Check14 days agoChange DetectedThe page's navigation labels were updated to include How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment, while the label Intervention / Treatment and Revision: v3.5.5 were removed and the revision tag updated to v3.6.0. A recruitment notice stating 'No longer looking for participants' was added to reflect enrollment status.SummaryDifference0.2%

- Check21 days agoChange DetectedA new revision tag, v3.5.5, was added, replacing v3.5.4, indicating an updated document version. This did not alter substantive page content.SummaryDifference0.0%

- Check28 days agoChange DetectedThe related topics/resources area in the study details page has been shortened by removing the Lung cancer and MedlinePlus Genetics entries, along with the related topics header. This narrows the list of linked topics presented to users.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a small internal maintenance update. No changes to study details, endpoints, or visible content were made.SummaryDifference0.0%

- Check50 days agoChange DetectedLung cancer and related topics were added under MedlinePlus related topics. The location entry was updated from Taoyuan District, Taiwan, 33305 to Taoyuan, Taiwan, 33305.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo with Chemo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo with Chemo in NSCLC Clinical Trial page.